Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells by Delsite, Robert et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Molecular Cancer
Open Access Molecular Cancer  2002,  1 x Research
Nuclear genes involved in mitochondria-to-nucleus communication 
in breast cancer cells
Robert Delsite1,2, Sushant Kachhap1, Ramaswamy Anbazhagan1, 
Edward Gabrielson1 and Keshav K Singh*1
Address: 1Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, 
Room 143, Baltimore, MD 21231, USA and 2Present address: Department of Radiation Oncology, Massachusetts General Hospital, 149 13th 
Street, Charlestown, MA 02129, USA
E-mail: Robert Delsite - RDELSITE@PARTNERS.ORG; Sushant Kachhap - sushantkk@yahoo.com; Ramaswamy Anbazhagan - anba@jhmi.edu; 
Edward Gabrielson - egabriel@jhmi.edu; Keshav K Singh* - singhke@jhmi.edu
*Corresponding author
Keywords: Mitochondria, Mitochondrial DNA, Nuclear genes, Breast Cancer, Cancer
Abstract
Background:  The interaction of nuclear and mitochondrial genes is an essential feature in
maintenance of normal cellular function. Of 82 structural subunits that make up the oxidative
phosphorylation system in the mitochondria, mitochondrial DNA (mtDNA) encodes 13 subunits
and rest of the subunits are encoded by nuclear DNA. Mutations in mitochondrial genes encoding
the 13 subunits have been reported in a variety of cancers. However, little is known about the
nuclear response to impairment of mitochondrial function in human cells.
Results: We isolated a Rho0 (devoid of mtDNA) derivative of a breast cancer cell line. Our study
suggests that depletion of mtDNA results in oxidative stress, causing increased lipid peroxidation
in breast cancer cells. Using a cDNA microarray we compared differences in the nuclear gene
expression profile between a breast cancer cell line (parental Rho+) and its Rho0 derivative
impaired in mitochondrial function. Expression of several nuclear genes involved in cell signaling,
cell architecture, energy metabolism, cell growth, apoptosis including general transcription factor
TFIIH, v-maf, AML1, was induced in Rho0 cells. Expression of several genes was also down
regulated. These include phospholipase C, agouti related protein, PKC gamma, protein tyrosine
phosphatase C, phosphodiestarase 1A (cell signaling), PIBF1, cytochrome p450, (metabolism) and
cyclin dependent kinase inhibitor p19, and GAP43 (cell growth and differentiation).
Conclusions: Mitochondrial impairment in breast cancer cells results in altered expression of
nuclear genes involved in signaling, cellular architecture, metabolism, cell growth and
differentiation, and apoptosis. These genes may mediate the cross talk between mitochondria and
the nucleus.
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Background
Mitochondria participate in numerous functions in the
cell. In addition to producing energy, mitochondria are
involved in intermediary metabolism, ion homeostasis,
synthesis of lipids, amino acids, and nucleotides, active
transport processes, cell motility, and cell proliferation
[1–4]. Recent developments also demonstrate that mito-
chondria are key regulators of programmed cell death [4].
Mitochondrial dysfunction is one of the most profound
features of cancer cells. Several distinct differences be-
tween the mitochondria of normal cells and cancer cells
have been observed at the microscopic, molecular, bio-
chemical, metabolic and genetic levels [5]. Microscopic
study of oncocytic tumors revealed mitochondrial hyper-
plasia [6], and differential expression of mitochondrial cy-
tochrome oxidase II in benign and malignant breast
tissues has also been reported [7]. Furthermore, muta-
tions in mitochondrial DNA (mtDNA) are commonly
found in a variety of cancers including the ovarian, thy-
roid, salivary, kidney, liver, lung, colon, gastric, brain
bladder, head and neck, leukemia and breast cancers [8].
Mitochondrial DNA encodes two rRNA, 22 tRNA and 13
proteins [2]. Each of the polypeptides form subunits of
four respiratory enzyme complexes localized to the inner
mitochondrial membrane [2]. These subunits include sev-
en subunits of respiratory enzyme complex I, one subunit
of complex III, three subunits of complex IV, and two sub-
units of complex V [2]. All other mitochondrial proteins,
including those involved in the replication, transcription
and translation of mtDNA, are encoded by nuclear genes
and are targeted to the mitochondrion by a specific trans-
port system [2]. Although the mitochondrial and nuclear
genomes are physically distinct, there is constant commu-
nication between the two genomes to carry out many of
the mitochondrial functions. For example, in the yeast
Saccharomyces cerevisiae, RTGproteins monitor the func-
tional state of mitochondria and mediate the intergenom-
ic communication between the mitochondria and the
nucleus. In this organism, RTG regulates transcription of
numerous genes involved in several pathways that help
cells adapt to mitochondrial dysfunction [9]. In addition,
yeast cells shift their metabolic profile by altering expres-
sion of a number of genes that respond to depletion of the
mitochondrial genome [9]. As in the case of yeast, the de-
pletion of mitochondrial DNA from human cell lines
leading to the generation of cell lines devoid of mtDNA
(denoted Rho0) provides an opportunity to study nuclear
responses to impairment of mitochondrial function. In
the present study we isolated a Rho0 derivative of a breast
cancer cell line. Our results demonstrate that Rho0 deriv-
ative experience increased oxidative stress and has im-
paired mitochondrial function. Using cDNA microarray
we compared differences in the nuclear gene expression
profile between parental Rho+ breast cancer cell line and
its Rho0 derivative. Our study suggests a variety of struc-
tural genes as well as genes involved in cellular signaling
and transcriptional regulation are differentially regulated
in Rho0 breast cancer cells.
Methods
Reagents
The plasmid containing the mitochondrial DNA-specific
probe, pTZ19/K5, was a generous gift from Dr. Michael
King (Thomas Jefferson University, USA). The probe has
bases 2578–4122 of the human mitochondrial genome
corresponding to a portion of the NADH dehydrogenase I
gene, subcloned into the pTZ19 plasmid. Chemical rea-
gents were obtained from Sigma-Aldrich, Corp. (St. Louis,
MO) unless otherwise indicated.
Cell Culture
MDA-MB-435 cells were obtained from American Type
Culture Collection, and maintained in Dulbecco's modi-
fied Eagle's medium/ Ham's F-12 (50:50 mix) (Mediate-
ch, Herndon, VA) supplemented with 10% fetal bovine
serum (GIBCO/Invitrogen Life Technologies, Carlsbad,
CA), 2 mM L-glutamine, penicillin, streptomycin, and 50
µg/ml uridine. For measurement of cell growth in glucose
and galactose, a 50:50 mix glucose-free Dulbecco's modi-
fied Eagle's medium (Sigma-Aldrich) and glucose-free
Ham's F-12 (Biofluids, Rockville, MD) was used. Either
glucose or galactose was added to 3.15 g/L, and the medi-
um was supplemented as described above. Cells were cul-
tured in a water-humidified incubator at 37°C in 10 %
CO2/90% air. Medium was replenished every 2 days.
Generation of ρ0 Cell Line
Cells were cultured in the routine growth medium con-
taining 50 ng/ml ethidium bromide (0.22 µm-filtered)
with regular replenishment of medium. After a minimum
of 30 days culture, single cell clones were isolated by lim-
iting dilution in 96 well culture clusters, in the presence of
ethidium bromide. The mtDNA status of clones was deter-
mined by Southern blotting, after which Rho0 clones were
maintained in medium without ethidium bromide. Cells
were screened after a minimum of 30 population dou-
blings in the absence of ethidium bromide to verify con-
tinued Rho0 status.
MtDNA Southern blotting
Total cellular DNA was isolated from washed exponential-
ly growing cells extracted in 10 mM Tris-Cl, pH 7.5, 5 mM
MgCl2, 320 mM sucrose, 1% Triton X-100, 0.1 mg/ml
proteinase K, 0.58% sodium dodecyl sulfate at 37°C for 2
h. An equal volume of phenol/chloroform/isoamyl alco-
hol (25:24:1) (Fisher Scientific, Pittsburgh, PA) was added
to the extracts, and DNA was isolated from the aqueous
phases after phase separation by centrifugation. After a
second round of phenol/chloroform/isoamyl alcohol ex-Molecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/6
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traction, DNA was cleaned with chloroform/isoamyl alco-
hol (25:1), twice with diethyl ether, and precipitated.
Three µg of total DNA were digested with PvuII, which
cuts a single site in the mitochondrial genome. Linearized
DNA was electrophoresed on a 0.8% agarose gel in TAE
containing ethidium bromide, and photographed. The
DNA was denatured and transferred to Nytran SuPer-
Charge membrane (Schleicher & Schuell, Keene, NH) us-
ing TurboBlotter (Schleicher & Schuell, Keene, NH) rapid
downward transfer with the alkaline transfer conditions
recommended by the manufacturer. DNA was crosslinked
by UV (1200 joules) and the membrane was prehybrid-
ized at 65°C for 4 h in 3X SSC, 0.25% milk powder, 0.25%
SDS. Oligonucleotide probe was excised from pTZ19 (K5)
by digestion with HindIII and EcoRI and isolated from
low melting point agarose gel using β-agarase (New Eng-
land Biolabs, Beverly, MA). Probe (25 ng) was labeled
with  32P-deoxycytidine (New England Nuclear/ Perkin
Elmer Life Sciences, Boston, MA) by RadPrime random
primer labeling (Invitrogen) and unincorporated nucle-
otides were removed by Concert ™ PCR purification kit (In
Vitrogen). After hybridization with labeled probe for a
minimum of 12 h, the membrane was washed twice with
2X SSC, 0.25% milk powder, 0.25% SDS for 30 min, and
twice for 30 min with 0.5X SSC, 0.25% milk powder,
0.25% SDS. All washes were performed at 65°C. Hybridi-
zation was visualized by autoradiography with X-ray film
(Kodak) at -80°C.
Cytochrome oxidase immunoblotting
Exponentially growing cells were washed with ice-cold
PBS, and collected in AG Buffer(0.3 M PMSF,0.9% Na-
Cl,0.1% Triton X,1 mM EDTA,0.5% NP40,50 mM
Na2HPO4), PMSF (100 µg/ml), leupeptin(2 µg/ml), and
aprotinin (2 µg/ml). Extracts were homogenized for 20
strokes on ice and protein concentration was estimated
using the Bio-Rad protein assay (Bio-Rad Laboratories,
Hercules, CA). Equal amounts of protein were separated
by SDS-PAGE on 12% polyacrylamide gels under denatur-
ing conditions. Proteins were transferred to Immobilon-P
nylon membrane by electrophoresis, and protein transfer
visualized by staining with Ponceau S and destaining with
deionized water. The membrane was blocked in 5% milk
in TBST overnight at 4°C, washed with TBST and hybrid-
ized with mouse anti-cytochrome oxidase II (Molecular
Probes Inc., Eugene, OR) 1:1000 in 3% milk/TBST for 1 h
at room temperature. After washing, membranes were hy-
bridized with horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) at 1:5000 in 3% milk/TBST for 1 h at
room temperature, washed, and incubated with ECL
chemiluminescence solution. Antibody binding was visu-
alized by exposure of membrane to X-ray film and subse-
quent processing. Membranes were stripped at 50°C in,
washed extensively with TBST, blocked and hybridized as
described above using a mouse anti-actin primary anti-
body at 1:1000 and HRP-conjugated goat anti-mouse IgG
secondary antiserum as described above.
Cell growth in glucose or galactose
The Rho+ and Rho0 cells were plated in 24 well tissue cul-
ture clusters (50,000 cells/well) in growth medium con-
taining 3.15 g/L glucose. After overnight culture, cells were
washed three times with PBS, and growth medium con-
taining either glucose or galactose (3.15 g/L) was added
back to the cells. MTT at a final concentration of 1 µg/ml
was added to triplicate wells of both cell lines grown in
both carbon sources immediately (t = 0) and at 24, 48,
and 96 h following medium change. MTT was also added
to one well containing each medium only, as a control.
After 4 h incubation with MTT, medium was aspirated, the
converted MTT-formazan extracted with DMSO, NaCl,
glycine, pH 10.5, and the absorbance at 553 nm was
measured by spectrophotometer.
Measurement of lipid peroxidation
Thiobarbituric acid reactivity was measured by a modifi-
cation of Ohkawa et al., [10] as described by Bowie et al.
[11]. Subconfluent cultures were collected by trypsiniza-
tion, washed with ice cold PBS and lysed by three freeze/
thaw cycles in sterile deionized water. Protein concentra-
tion of samples was estimated using Bio-Rad Protein As-
say Reagent compared with BSA standards. 1',1',3',3'-
tetramethoxypropane (TMP) was diluted to 10 mM in 20
mM Tris-Cl, pH 7.5, and serially diluted for standards.
Equal volumes (200 µl) of lysate or TMP standards were
mixed with 800 µl of solution containing 4 mg/ml 2-thio-
barbituric acid (TBA), 0.5% SDS, and 9.4% glacial acetic
acid, and heated at 95°C for 1 h. Samples were cooled to
room temperature, centrifuged for 10 min at 16,000 × g,
and the absorbances of the supernatants were read at 532
nm. Concentrations of TBA-reactive substances were esti-
mated by comparing values to TMP standard curve.
Microarray analysis
Total RNA was extracted from exponentially growing cells
with Trizol. Precipitated RNA was resuspended in DEPC-
treated deionized water, and concentration was estimated
by absorbance at 260 nm. Labeled cDNA was prepared by
RT-PCR according to the Array-Advantage UA protocol
from Ambion (Ambion Inc., Austin, TX). Briefly, 5 µg ex-
perimental RNAs and 1 µl alignment control RNA were
denatured at 70°C for 10 min and allowed to anneal to ol-
igodT by cooling to room temperature for 5 min. M-MLV
reverse transcriptase (400 units), [α-33P] dATP, dCTP,
dGTP, dTTP and 2 µl 10X RT buffer were added to a final
reaction volume of 20 µl, and RT reaction proceeded for 2
h at 42°C. Unincorporated nucleotides were removed by
passing reaction through NucAway™ Spin Column and ra-
diolabel incorporation of the reaction determined by liq-Molecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/6
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uid scintillation counting. Human LifeGrid Array
membranes (Incyte Genomics, Palo Alto, CA), which con-
tain 8000 cloned genes spotted in two positions on each
filter, were used for analysis. Membranes were blocked
with heat denatured herring sperm DNA and prehybrid-
ized for 1 h with 15 ml ULTRArray Hybridization Buffer at
68°C. Labeled cDNA from each RT reaction was heat de-
natured at 95°C for 5 min, added to the prehybridization
buffer, and hybridized to an array for 16 h at 68°C. Mem-
branes were washed twice 30 min each with 2X SSC, 0.5%
SDS, followed by 0.5X SSC, 0.5% SDS, at 60°C. Mem-
branes were exposed to phosphorimager screen for 3 hr,
and imaged as .gel files using a phosphorimaging scanner
with TyphoonScan (Molecular Dynamics, Amersham Bio-
sciences, Piscataway, NJ) software. Spot intensities were
measured using ArrayVision software (Imaging Research,
Inc., St. Catharines, Ontario, Canada), and the values.
Genes corresponding to differentially expressed RNAs
were identified by Incyte Genomics clone identification
numbers. Membranes were stripped and reconstituted ac-
cording to the manufacturer's instructions, and hybridiza-
tions repeated using freshly labeled cDNAs. In repeats,
each cDNA was hybridized to the opposite membrane
from that to which it had been previously hybridized.
Only those genes that were consistently differentially ex-
pressed in 3 hybridizations were selected for analysis.
RT-PCR analysis
Trizol reagent (In Vitrogen) was used to isolate RNA from
106 cultured cells according to the manufacturer's instuc-
tion. One and half micrograms of total RNA was reverse
transcribed using Superscript II Rnase H- reverse tran-
scriptase (In Vitrogen). Two microlitres of the reverse tran-
scribed products was used in the PCR reactions. Primers
were made for a twenty of the differentially expressed
genes and for G3PDH a housekeeper gene. Twenty five
microlitres of the PCR reactions contained 20 mM Tris-
HCL, pH 8.4, 50 mM KCl, 1.5 mM MgCl2, 200 µM dNTP
and 10 picomoles of each primer and one unit of Taq
DNA polymerase (Invitrogen). Each gene was amplified
by PCR using various cycle numbers ranging from 30 to
55 cycles to ascertain its linear amplification. In general
the PCR profile consisted of an initial denaturation at
94°C for 5 minutes and a variable number of cycles of de-
naturation at 94°C for 45 sec, annealing at 58°C for 1 min
and extension for 2 min at 72°C with a final extension at
72°C for 10 min. To aid comparison five microliters of the
PCR products of the differentially regulated genes were
mixed with an equal amount of the housekeeper gene
products and electrophoresed on a 1% agarose gel and vis-
ualized after staining with ethidium bromide (0.5 µg/ml)
under ultra violet.
Results
Generation of Rho0 breast cancer cell line
The rarity of recombination in the replication of mtDNA
is prohibitive to the possibility of selectively inactivating
mtDNA encoded genes by homologous recombination
[12]. However, by culturing cells in the presence of low
concentrations of ethidium bromide, it is possible to pref-
erentially inhibit the replication of mtDNA, generating a
cell line that are devoid of the mitochondrial genome
[13]. These cells, denoted Rho0, have altered metabolic re-
quirements due to the loss of components of the electron
transport chain, and require both uridine and pyruvate for
growth [13]. Cells with this engineered mitochondrial
dysfunction require exogenous uridine because a func-
tional electron transport chain is needed for pyrimidine
biosynthesis [13]. We generated a mtDNA-depleted vari-
ant of the breast cancer cell line MDA-MB-435 by cultur-
ing cells with EtBr (50 ng/ml) for approximately 90 cell
generations, then isolating clones by limiting dilution.
Total DNA from this Rho0 clone (clone 7) was digested
with PvuII, which cuts at a single site in mtDNA. Southern
blotting, and hybridization with a mtDNA-specific probe
showed the presence of a 16.6 kb band in the MDA-MB-
435 Rho+ cell line. The 16.6 kb fragment was absent in the
Rho0 cell line (Figure 1A,1B). To further verify loss of
mtDNA encoded protein, the expression of mtDNA-en-
coded cytochrome oxidase II (COX II) was assessed by
western blotting. Expression is not observed in Rho0 cell
lysates as compared to the parental cells (Figure 2A and
2B). To assess the growth characteristics of the Rho0 clone,
cell growth was measured in glucose and galactose media.
Cells with dysfunctional mitochondria are unable to effi-
ciently utilize galactose as a primary carbon source for en-
ergy production (14). Following an initial growth lag,
parental MDA-MB-435 cells grown in galactose medium
proliferated at a rate comparable to the rate observed in
glucose (Figure 3A). However, Rho0 cells were unable to
grow in galactose media, indicating an impairment of mi-
tochondrial function (Figure 3B). These results demon-
strated that we had isolated Rho0 breast cells that do not
express protein encoded by mtDNA, and which lack prop-
er mitochondrial function.
Increased lipid peroxidation in Rho0 cells
Mitochondria are the major site of reactive oxygen (ROS)
production [1,2] OS cause oxidative damage. It is conceiv-
able that altered mitochondrial function in Rho0 leads to
increased oxidative stress. We therefore measured lipid
peroxidation in parental and Rho0 breast cancer cells.
Malondialdehyde, a product of the catabolism of peroxi-
dized lipids, forms a pigmented reaction product with
thiobarbituric acid that can be measured spectrophoto-
metrically [10,11]. Levels of thiobarbituric acid-reactive
species were measured in extracts of parental Rho+ and
Rho0 cells to determine if altered mitochondrial functionMolecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/6
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results in lipid peroxidation. Figure 4 shows that thiobar-
bituric acid-reactive species were increased in Rho0 cells
(solid bar) compared to the Rho+ parental cells (open
bar). We conclude that an increase in lipid peroxidation is
associated with the impairment of mitochondrial func-
tion.
Microarray analysis
Nuclear and mitochondrial genomes interact at least in
two possible ways. First they contribute essential protein
subunits to important mitochondrial function; second
they collaborate in the synthesis of and assembly of mito-
chondrial proteins [14]. To identify genes that respond to
lack of mtDNA encoded genes, we compared the mRNA
level between the Rho0 cell line and parental Rho+ cell
line by cDNA microarray analysis. We analyzed 8000
genes present in the array. The microarray analysis re-
vealed that 35 genes were significantly up regulated and
22 genes were down regulated in Rho0 cells (Table 1 and
2). The differentially expressed genes were classified into
various classes including transcription factors and archi-
tectural proteins (Table 1 and 2). Eight genes were selected
randomly to confirm the microarray results by RT-PCR.
The messages for each particular gene needed different cy-
cle numbers to assess the exponential amplification accu-
rately indicating the relative abundance of the individual
messages. The RT-PCR results confirmed differential ex-
pression of the genes indicated by the microarray results
(Figure 5, Tables 1 and 2). RT-PCR results show (Figure 5)
that p19 (cyclin dependent kinase inhibitor) and v-maf
were maximally up regulated followed by phospholipase
C epsilon, a gene involved in signalling by increasing the
intracellular levels of calcium ions. Among the down reg-
Figure 1
Southern blot analysis of mtDNA. Total DNA was
extracted from parental MDA-MB-435 cells (Lanes 1A, 1B)
and the clone 7 mtDNA-depleted variant of MDA-MB-435
cells (Lanes 2A, 2B), (A): Total DNA was then digested with
PvuII (which cuts a single site in mtDNA generating a single
16.6 Kb fragment), separated by electrophoresis on agarose
gel containing ethidium bromide. (B) DNA was transferred
to nylon membrane, and the membrane was hybridized to a
32P-labeled mtDNA-specific DNA probe. The 16.6 Kb
mtDNA is present in parental MBA-MD-435 cells (Lane 1B),
but absent in Clone 7 (Lane 2B). The 16.6 Kb genome is indi-
cated by arrow.
A B
2 2 1 1 kb
23,130
9,416
6,557
4,361
2,322
2,027
Figure 2
Rho0 cells do not express mtDNA-encoded COX II
protein. Equal amounts of total cell lysates from parental
MDA-MB-435 (Lane 1) and Clone 7 Rho0 variant (Lane 2)
cells were separated by SDS-PAGE and transferred to a
membrane. (A) Blot was hybridized with a monoclonal anti-
body against cytochrome oxidase II (COXII), and (B) then
stripped and rehybridized with a monoclonal antibody against
??-actin. COXII staining demonstrates the loss of expression
of the mtDNA-encoded COXII (Lane 2A). Actin staining
shows that protein loading is approximately equal (Lanes 1B,
2B).Molecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/6
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ulated genes phospholipase A2 was maximally down reg-
ulated, followed by progesterone-induced blocking factor
1 (PIBF1) a protein that acts on the phospholipase A2 en-
zyme and interferes with arachidonic acid metabolism.
These results suggest that impairment of mitochondrial
function leads to altered expression of nuclear genes in-
volved in communication between mitochondria and nu-
cleus.
Discussion
This paper reports on a comprehensive analysis of the nu-
clear gene expression in response to the absence of mtD-
NA in breast cancer cells. We demonstrate that expression
of a number of nuclear genes is altered in response to the
absence of mtDNA in breast cancer cells. These genes
ranged from transcription factors to genes that are in-
volved in metabolism, cell architecture and signaling. Our
results are consistent with previous studies in yeast and
mammalian cells that reported altered pattern of nuclear
gene expression due to elimination of mtDNA [15–17].
We conducted comparative microarray analysis on Rho+
MDA-435 cell line and its Rho0 derivative. Rho0 cells have
been used extensively to study the role of mitochondria in
a variety of cellular processes that are affected by mito-
chondrial dysfunction (16, 17, 18). Our results showed
that 35 genes are up regulated (> 3 fold) and 22 are down
regulated (>3 fold) in Rho0 breast cancer cells. We chose
10 genes randomly to confirm the results of microarray
Figure 3
Rho0 cells do not grow in galactose medium. Rho+
(MDA-MB-435) cells and Rho0 cells were grown in custom-
made medium containing galactose (instead of glucose, pur-
chased from Sigma). While MDA-MB-435 cells continue to
grow in this medium (A), Rho 0 clone 7 cells began to die
after 48 hours (B).
Figure 4
Lipid peroxidation is increased due to dysfunction in
mitochondria: Subconfluent cultures were collected by
trypsinization, washed with ice cold PBS and lysed by freeze/
thaw cycles in sterile deionized water. Lipid peroxidation was
measured as described in material methods.
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Figure 5
RT-PCR analysis: RT-PCR analysis of up-regulated or
down regulated genes was carried out as described in mate-
rial methods.
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analysis with RT-PCR (Figure 5). Among genes that are up
regulated in Rho0 cells p19 (INK4d), a cyclin dependent
kinase inhibitor, is focally expressed during fetal develop-
ment and plays a role in terminal differentiation [19].
Members of the group of INK proteins are involved in ar-
resting cells in G1 phase of the cell cycle. Conceivably,
p19 may be involved in the observed slow growth rate of
the Rho0. A number of genes that influence gene tran-
scription are differentially expressed after mitochondrial
impairment. The Maf oncoprotein, a basic leucine zipper-
bearing transcriptional activator that recognizes the Maf
recognition element (MARE) DNA sequence (20) is no-
ticeably up regulated in the Rho0 cell line. c-MAF is highly
expressed in developing skeletal tissues, cells where mito-
chondria play a central role in their functioning [20,21].
The transcription factors TFIIH and AML1 were also up
regulated in the Rho0 cell lines. TFIIH is associated with
the RNA polymerase II transcription complex, which is in-
volved in transcription and transcription-mediated DNA
repair [22]. The transcription factor AML1 is frequently
found translocated in leukemic cells [23]. Conceivably, al-
tered expression of these transcriptional regulators in re-
sponse to mitochondrial impairment could directly or
indirectly lead to the changes in expression of other genes
seen in Rho0 cells.
Phosphoinositide-specific phospholipase C (PLC) ∈ was
among the signaling molecules that were up regulated in
the Rho0 cell line. PLC is a critical signaling enzyme that
hydrolyzes membrane phospholipids to generate inositol
trisphosphate (IP3), which binds to IP3 receptors and in-
creases intracellular Ca2+[24]. The ∈ isoform of PLC is a
novel effector of ras[25,26]. Another signaling molecule
of significance that is up regulated in the Rho0 cells is the
Slit (Drosophila) homolog 3. Three vertebrate orthologs
of the fly slit gene, Slit1, 2, and 3, have been isolated. Each
displays overlapping, but distinct, patterns of expression
in the developing vertebrate central nervous system, im-
Table 1: Genes Up-regulated in Rho0 cells (≥ 3 fold)
Function Gene
Transcription v-maf protein G
General transcription factor IIH polypeptide 3
IFN consensus sequence binding protein 1
Nuclear autoantigen
Runt-related transcription factor 1(AML-1Oncogene)
Cell Signalling Slit(Drosophila) homolog 3
Phospholipase C, epsilon
Syanaptojanin 2
HLA DR beta 5
Cell Architecture Tubulin specific chaperone D
Hyaluronglucosaminidase 1
Collagen Type IV
Gap Junction Protein 43
Metabolism Apolipoprotein D
Arylacetamide deacytylase (esterase)
Neuromedin U
ATP5A1
UDP-galactose:N-acetylglucosamine beta-1, 4-galactosyltransferase I
Cysteine dioxygenase type I
Cell growth and differentiation Cyclin-dependent kinase inhibitor P19
Microtubule-associated protein 4
CDC28 protein kinase
CD34
Apoptosis TNF superfamily member 6, (Fas Ligans)
Ectodermal dysplasia 1, anhidrotic.
Unknown FBR89
FLJ23231
ESTs, Weakly similar to AAB47496 NG5 [H. sapiens]
EST
FLJ13164
Uncharacterized Bone marrow protein, BM033
FJ 10407Molecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/6
Page 8 of 10
(page number not for citation purposes)
plying conservation of function [27]. Slit3 gene product is
the least evolutionarily conserved of the vertebrate Slit
genes. The fact that Slit3, but not Slit2, is predominantly
localized within the mitochondria makes its up regulation
in the Rho0 cells an intriguing phenomenon [28].
One feature of the Rho0 cell line is the differential expres-
sion of certain genes that are involved directly or indirect-
ly in metabolism of fatty acids or signaling (Figure 5 and
Table 1 and 2). Among those that are up regulated are
apolipoprotein D (ApoD) and arylacetamide deacetylase.
While ApoD may have a similar function as the other ap-
oproteins, it does not share a similar protein structure to
the other family members, and does not bind cholesterol
with high affinity [29]. Hence, it may have a unique effect
via binding of different ligands. ApoD may be involved in
the binding of steroids or fatty acids, Apo D interacts with
Ob-Rb, but not Ob-Ra, in hypothalamic neurons in vi-
vo[29]. In the central nervous system it was found that
Apo D may be activated through its interaction with a lep-
tin-stimulated Ob-Rb and may bind a specific ligand in
hypothalamic neurons, where it exerts signaling functions
[30]. Arylacetamide deacetylase may also function as a li-
pase during the process of lipoprotein secretion [31,32].
Other genes involved in fatty acid signaling were down
regulated in Rho0 cells. These include phospholipase A2,
a protein closely involved with arachidonic acid metabo-
lism and also involved with cell signaling [33–35], that
was found to be maximally down regulated in Rho0 cells.
Phospholipase A2 also plays a role in the translocation of
PKC-mediated by fatty acids. Another gene with functions
closely related to the arachidonic acid metabolism that is
down regulated in the Rho0 cells is the progesterone-in-
duced blocking factor 1 (PIBF1). PIBF1 is known to act on
the phospholipase A2 enzyme, and so interferes with ara-
chidonic acid metabolism, inducing a Th2 biased im-
mune response [36]. PIBF1 exerts an anti-abortive effect
by controlling NK activity [37]. A gene related to lipid sig-
naling that encodes agouti-related protein was also down
regulated in the Rho0 cells. Agouti is a paracrine-signaling
factor that acts to block melanocortin action [38,39]. Dis-
ruption of melanocortin signaling with antagonist admin-
istration leads to an increase in feeding and eventually to
obesity. Such blockage has been observed in both lipopol-
ysaccharide-induced animals and also during illness [40].
The data exhibiting down regulation of the agouti gene is
further strengthened by the down regulation of the LPS re-
ponse-68 protein in the Rho0 cells.
The ATP synthase 5A1 subunit gene that is directly in-
volved in mitochondrial function was up regulated in the
Rho0 cell lines. ATP synthase is a multimeric complex
composed of at least 16 different polypeptides, two of
which are mitochondrially encoded, and the remainder
encoded by nuclear genes [2]. Certain leukemic cells show
an increased production of the ATP5A1 subunit [41]. In-
Table 2: Genes Down regulated in Rho0 (≥ 3 fold)
Function Gene
Transcription Dachshund (Drosophila) Homolog
Cell Signaling LIM binding domain 2
Phospholipase A2 Group IB
Phospholipase C, epsilon
Lipopolysaccharide response-68 protein
Agouti related protein
PKC, gamma
Protein Tyrosine Phosphatase, Receptor Type c, Polypeptide-Associated Protein
Neurotensin Receptor I
Phosphodiesterase 1A, calmodulin dependent
Cell Architecture Adaptor related protein complex 4 mu 1 subunit
Synuclein gamma
Thymopoietin
Metabolism PIBF1
Carboxypeptidase B2 (plasma)
Cytochrome P 450 subfamily VIIB, polypeptide 1
Protective protein for beta-galactosidase
Cell growth and differentiation Cyclin-dependent kinase inhibitor P19
GAP-43
Intracellular Protein degradation Huntingtin interacting protein B
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terestingly, a down regulated gene CYP7B1 encoding an
oxysterol 7 alpha-hydroxylase (Cytochrome P450 sub-
family VII BI) is involved in many metabolic processes in-
cluding bile acid synthesis and neurosteroid metabolism
[42].
Mitochondria control Ca++ homeostasis [2]. Protein ki-
nase C γ, neurotensin receptor, and neuromodulin (GAP-
43) are among the genes that are involved in calmodulin
regulation or related to calmodulin function [43–45]
which are down regulated in Rho0 cells. Neuromodulin is
also a substrate for phosphorylation by protein kinase C
[46] which may reflect an influence of mitochondrial
function on multiple members of a signal transduction
pathway. Another interesting feature in the expression
profile of cells lacking mtDNA is the low expression of
many genes that play a role in the development and main-
tenance of the nervous system [47,48]. Of particular inter-
est is the gene that encodes neurotensin receptor I, a short
peptide receptor for neurotensin that exerts neuromodu-
latory functions in the central nervous system and endo-
crine/paracrine actions in the periphery [49].
Neuromodulin is also involved in the growth and regen-
eration of axons, and in the elongation of axons as an ax-
onal transport membrane protein [45]. Synuclein is
expressed in the nervous tissues and mutations in this
gene are associated with rare familial cases of early-onset
Parkinson's disease [50]. Gamma synuclein is also in-
volved in tumorigenesis [42]. PKC-g mutation has been
shown to lead to neurodegeneration [51]. Dachshund, a
putative transcription factor, plays a role in retinal devel-
opment [52]. Huntingtin-interacting protein-2 is involved
in the neurodegenerative Huntington disease [53].
In summary, our data provides an overview of the genes
that are involved in the nuclear and mitochondrial cross
talk and respond to oxidative stress manifested due to im-
paired mitochondrial function. The identification of a
large number of genes whose expression is influenced by
mitochondrial function provides a foundation for future
investigation of the pathways affected by the impairment
of mitochondria in pathological conditions. An under-
standing about the role of the proteins in the maintenance
of proper mitochondrial function and in oxidative stress
response is critical for understanding the role of mito-
chondria in carcinogenesis.
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